| 31337857 |
Targeting cell membrane HDM2: A novel therapeutic approach for acute myeloid leukemia
Wang, H,
Zhao, D,
Nguyen, LX,
Wu, H,
Li, L,
Dong, D,
Troadec, E,
Zhu, Y,
Hoang, DH,
Stein, AS,
Al Malki, M,
Aldoss, I,
Lin, A,
Ghoda, LY,
McDonald, T,
Pichiorri, F,
Carlesso, N,
Kuo, YH,
Zhang, B,
Jin, J,
Marcucci, G
|
Leukemia |
2020 |
| 29356040 |
Basolateral CD147 induces hepatocyte polarity loss by E-cadherin ubiquitination and degradation in hepatocellular carcinoma progress
Lu, M,
Wu, J,
Hao, ZW,
Shang, YK,
Xu, J,
Nan, G,
Li, X,
Chen, ZN,
Bian, H
|
Hepatology |
2018 |
| 18057010 |
Cdc42 regulates E-cadherin ubiquitination and degradation through an epidermal growth factor receptor to Src-mediated pathway
Shen, Y,
Hirsch, DS,
Sasiela, CA,
Wu, WJ
|
J Biol Chem |
2008 |
| 38045551 |
Dynamics and functions of E-cadherin complexes in epithelial cell and tissue morphogenesis
Zhang, N,
Häring, M,
Wolf, F,
Großhans, J,
Kong, D
|
Mar Life Sci Technol |
2023 |
| 22715382 |
Reduced surface expression of epithelial E-cadherin evoked by interferon-gamma is Fyn kinase-dependent
Smyth, D,
Leung, G,
Fernando, M,
McKay, DM
|
PLoS One |
2012 |
| 22693575 |
Competitive regulation of E-cadherin juxtamembrane domain degradation by p120-catenin binding and Hakai-mediated ubiquitination
Hartsock, A,
Nelson, WJ
|
PLoS One |
2012 |
| 25086032 |
Inhibition of epithelial to mesenchymal transition by E-cadherin up-regulation via repression of slug transcription and inhibition of E-cadherin degradation: dual role of scaffold/matrix attachment region-binding protein 1 (SMAR1) in breast cancer cells
Adhikary, A,
Chakraborty, S,
Mazumdar, M,
Ghosh, S,
Mukherjee, S,
Manna, A,
Mohanty, S,
Nakka, KK,
Joshi, S,
De, A,
Chattopadhyay, S,
Sa, G,
Das, T
|
J Biol Chem |
2014 |
| 25253721 |
Minus end-directed motor KIFC3 suppresses E-cadherin degradation by recruiting USP47 to adherens junctions
Sako-Kubota, K,
Tanaka, N,
Nagae, S,
Meng, W,
Takeichi, M
|
Mol Biol Cell |
2014 |
| 26280083 |
MTBP Promotes the Invasion and Metastasis of Hepatocellular Carcinoma by Enhancing the MDM2-Mediated Degradation of E-Cadherin
Lu, S,
Zhou, W,
Wei, H,
He, L,
Li, L
|
Dig Dis Sci |
2015 |
| 16751808 |
Raf plus TGFbeta-dependent EMT is initiated by endocytosis and lysosomal degradation of E-cadherin
Janda, E,
Nevolo, M,
Lehmann, K,
Downward, J,
Beug, H,
Grieco, M
|
Oncogene |
2006 |
| 11836526 |
Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex
Fujita, Y,
Krause, G,
Scheffner, M,
Zechner, D,
Leddy, HE,
Behrens, J,
Sommer, T,
Birchmeier, W
|
Nat. Cell Biol. |
2002 |
| 32805084 |
LncRNA UCA1 maintains the low-tumorigenic and nonmetastatic status by stabilizing E-cadherin in primary prostate cancer cells
Zhao, X,
Wang, Y,
He, J,
Deng, R,
Huang, X,
Guo, Y,
Li, L,
Xie, R,
Yu, J
|
Mol Carcinog |
2020 |
| 16980628 |
MDM2 promotes cell motility and invasiveness by regulating E-cadherin degradation
Yang, JY,
Zong, CS,
Xia, W,
Wei, Y,
Ali-Seyed, M,
Li, Z,
Broglio, K,
Berry, DA,
Hung, MC
|
Mol Cell Biol |
2006 |
| 19711372 |
An acidic extracellular pH disrupts adherens junctions in HepG2 cells by Src kinases-dependent modification of E-cadherin
Chen, Y,
Chen, CH,
Tung, PY,
Huang, SH,
Wang, SM
|
J Cell Biochem |
2009 |